Novo Nordisk’s Winning Strategy In China Infiltrates County Hospital Market
This article was originally published in PharmAsia News
Executive Summary
Ahead of the implementation of China’s newly expanded essential drug list, Novo Nordisk China Marketing VP Jack Chen talks to PharmAsia News on provincial tenders and the company’s strategy in the lower-tier markets.